Navigation Links
New Evidence Highlights Dangers of Mercury Toxicity in Fish
Date:10/8/2008

SAN FRANCISCO, Oct. 8 /PRNewswire/ -- Dr. Jane Hightower -- widely acknowledged as the first US physician to recognize low-level mercury poisoning in patients who regularly consume certain types of fish -- today released new evidence showing that the FDA has failed to inform and protect the public from the risks of mercury poisoning due to consumption of certain types of seafood. Dr. Hightower has released a new book, Diagnosis: Mercury: Money, Politics, and Poison, which is widely available in stores starting October 7, 2008.

"Common sense says that if you are not feeling well, and are eating poison, then stop eating it and see if you feel better," said Dr. Hightower. "The problem is that we are not given enough information about just how much mercury is in the fish that is widely available in stores and restaurants. Most American consumers are simply unaware that the fish they eat could be making them sick."

Using newly available legal testimony and investigative research into the source of the scientific data that inform the FDA's mercury consumption guidelines, Dr. Hightower has pulled together information that should concern everyone in the United States.

The FDA's current mercury consumption guidelines are rooted in a study of the victims of a mass methylmercury poisoning in Saddam Hussein's Iraq. While researchers from the University of Rochester and the World Health Organization wrote articles about the effects of mercury on these victims, Dr. Hightower shows that their conclusions were based on data provided by one of Hussein's government allies. And this associate in Iraq's health ministry -- who oversaw the study of Iraqi victims of mercury toxicity -- has recently revealed that he withheld information from researchers, information that might have shown severe effects at much lower levels of exposure.

When the FDA and the swordfishing giant Anderson Seafood Inc. went to court in the mid-1970s over the FDA's consumption guidelines, Anderson used the Iraqi study as proof that high levels of mercury exposure are safe for the general public. The company won its case based on the evidence presented in court. But in the course of Dr. Hightower's research she discovered that one of the lead investigators of the Iraqi poisoning disputed the fishing industry's claim of how much mercury is safe to eat. Even as government agencies around the world -- including our own EPA -- have moved away from the "safe" levels based on the Iraq studies, the FDA has failed to adequately warn the public that mercury-laden seafood is a major threat to their health. The concern reaches far beyond women of childbearing age and children.

"Diagnosis: Mercury brings together the strongest evidence to date that the FDA's guidelines for fish consumption are insufficient," said Chuck Savitt, president of Island Press, which published the book. "We simply don't know how widespread low-level mercury toxicity is in the United States, and this book tells us that regular consumers of certain types of fish are in danger."

Hightower's research spans from individual patients in her practice to widespread mercury poisonings in Japan, Canada, and Iraq. Diagnosis: Mercury makes a powerful case for increased study and stronger FDA regulation of this poison in our food supply.


'/>"/>
SOURCE Island Press
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Evidence-Based Investing: M.D. Turned Financial Advisor Diagnoses What Ails Most Investors
2. DIA Conference to Provide New Paradigms in Evidence-Based Medicine and Health Technology Assessment
3. First Comprehensive Reference on Evidence-Based Design Published
4. Louisiana May Mandate Fluoridation Despite Evidence of Harm
5. Experts from 10 countries develop first evidence-based definition of lifelong premature ejaculation
6. Researchers find first conclusive evidence of Alzheimers-like brain tangles in nonhuman primates
7. New Evidence Provides Clinicians With Better Tools to Help Smokers Quit
8. Antidepressants do work in depression while evidence for CBT is poorer say experts
9. Evidence that stun guns may stimulate the heart
10. Promising early evidence of the superior benefits of drug therapy for diabetic eye disease
11. Experts Agree There is No Scientific Evidence of Health Risks in New Jersey Synthetic Turf Fields
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: